306
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations

, ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 1967-1976 | Published online: 11 Aug 2020

References

  • HeronM. Leading Causes for 2015. Hyattsville, MD: National Center for Health Statistics; 2017.
  • PereraPN, ArmstrongEP, SherrillDL, SkrepnekGH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9(2):131–141. doi:10.3109/15412555.2011.65023922409371
  • DhamaneAD, MoretzC, ZhouY, et al. COPD exacerbation frequency and its association with health care resource utilization and costs. Int J Chron Obstruct Pulmon Dis. 2015;10:2609–2618. doi:10.2147/COPD.S9014826664109
  • RennardSI, FarmerSG. Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(2):88–92. doi:10.1513/pats.230602616113418
  • HalpinDM, DecramerM, CelliB, KestenS, LiuD, TashkinDP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:653–661. doi:10.2147/COPD.S3418623055714
  • ConnorsAF Jr, DawsonNV, ThomasC, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959–967. doi:10.1164/ajrccm.154.4.88875928887592
  • SeemungalTA, DonaldsonGC, PaulEA, BestallJC, JeffriesDJ, WedzichaJA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi:10.1164/ajrccm.157.5.97090329603117
  • BahadoriK, FitzGeraldJM. Risk factors of hospitalization and readmission of patients with COPD exacerbation–systematic review. Int J Chron Obstruct Pulmon Dis. 2007;2(3):241–251.18229562
  • Garcia-AymerichJ, MonsoE, MarradesRM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001;164(6):1002–1007. doi:10.1164/ajrccm.164.6.200601211587986
  • HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
  • CaoZ, OngKC, EngP, TanWC, NgTP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology. 2006;11(2):188–195. doi:10.1111/j.1440-1843.2006.00819.x16548905
  • LauAC, YamLY, PoonE. Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Med. 2001;95(11):876–884. doi:10.1053/rmed.2001.118011716201
  • Bernabeu-MoraR, Garcia-GuillamonG, Valera-NovellaE, Gimenez-GimenezLM, Escolar-ReinaP, Medina-MirapeixF. Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study. Ther Adv Respir Dis. 2017;11(10):383–392. doi:10.1177/175346581772631428849736
  • FriedLP, TangenCM, WalstonJ, et al. Frailty in older adults: evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56(3):M146–M156. doi:10.1093/gerona/56.3.M14611253156
  • CesariM, GambassiG, van KanGA, VellasB. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–12. doi:10.1093/ageing/aft16024132852
  • CawthonPM, MarshallLM, MichaelY, et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007;55(8):1216–1223. doi:10.1111/j.1532-5415.2007.01259.x17661960
  • KulminskiAM, UkraintsevaSV, KulminskayaIV, ArbeevKG, LandK, YashinAI. Cumulative deficits better characterize susceptibility to death in elderly people than phenotypic frailty: lessons from the cardiovascular health study. J Am Geriatr Soc. 2008;56(5):898–903. doi:10.1111/j.1532-5415.2008.01656.x18363679
  • KennedyCC. Handgrip strength in chronic obstructive pulmonary disease: ready for prime time or frailty research tool? Ann Am Thorac Soc. 2017;14(11):1630–1631. doi:10.1513/AnnalsATS.201706-487ED29090996
  • MarengoniA, VetranoDL, Manes-GravinaE, BernabeiR, OnderG, PalmerK. The relationship between COPD and frailty: a systematic review and meta-analysis of observational studies. Chest. 2018;154(1):21–40. doi:10.1016/j.chest.2018.02.01429477493
  • LahousseL, ZiereG, VerlindenVJ, et al. Risk of frailty in elderly with COPD: a population-based study. J Gerontol a Biol Sci Med Sci. 2016;71(5):689–695. doi:10.1093/gerona/glv15426355016
  • GaliziaG, CacciatoreF, TestaG, et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res. 2011;23(2):118–125. doi:10.1007/BF335107621743290
  • KennedyCC, NovotnyPJ, LeBrasseurNK, WiseRA, SciurbaFC, BenzoRP. Frailty and clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(2):217–224. doi:10.1513/AnnalsATS.201803-175OC30433830
  • MartinezCH, DiazAA, MeldrumCA, et al. Handgrip strength in chronic obstructive pulmonary disease. associations with acute exacerbations and body composition. Ann Am Thorac Soc. 2017;14(11):1638–1645. doi:10.1513/AnnalsATS.201610-821OC29090990
  • BuiKL, NybergA, RabinovichR, SaeyD, MaltaisF. The relevance of limb muscle dysfunction in chronic obstructive pulmonary disease: a review for clinicians. Clin Chest Med. 2019;40(2):367–383. doi:10.1016/j.ccm.2019.02.01331078215
  • SwallowEB, ReyesD, HopkinsonNS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115–120. doi:10.1136/thx.2006.06202617090575
  • NguyenHQ, HertingJR, PikeKC, et al. Symptom profiles and inflammatory markers in moderate to severe COPD. BMC Pulm Med. 2016;16(1):173. doi:10.1186/s12890-016-0330-127914470
  • KatzJN, ChangLC, SanghaO, FosselAH, BatesDW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73–84. doi:10.1097/00005650-199601000-000068551813
  • CharlsonME, PompeiP, AlesKL, MacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
  • CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
  • WoodsNF, LaCroixAZ, GraySL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005;53(8):1321–1330. doi:10.1111/j.1532-5415.2005.53405.x16078957
  • JohansenKL, ChertowGM, JinC, KutnerNG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960–2967. doi:10.1681/ASN.200702022117942958
  • MathiowetzV, WeberK, VollandG, KashmanN. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984;9(2):222–226. doi:10.1016/S0363-5023(84)80146-X6715829
  • DoddsRM, SyddallHE, CooperR, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637. doi:10.1371/journal.pone.011363725474696
  • CindyNLW, JenkinsS, HillK. Accuracy and responsiveness of the stepwatch activity monitor and ActivPAL in patients with COPD when walking with and without a rollator. Disabil Rehabil. 2012;34(15):1317–1322. doi:10.3109/09638288.2011.64166622200080
  • NguyenHQ, BurrRL, GillDP, ColemanK. Validation of the StepWatch device for measurement of free-living ambulatory activity in patients with chronic obstructive pulmonary disease. J Nurs Meas. 2011;19(2):76–90. doi:10.1891/1061-3749.19.2.7622003809
  • Tudor-LockeC, BrashearMM, JohnsonWD, KatzmarzykPT. Accelerometer profiles of physical activity and inactivity in normal weight, overweight, and obese U.S. men and women. Int J Behav Nutr Phys Act. 2010;7(1):60. doi:10.1186/1479-5868-7-6020682057
  • Tudor-LockeC, RoweDA. Using cadence to study free-living ambulatory behaviour. Sports Med. 2012;42(5):381–398. doi:10.2165/11599170-000000000-0000022462794
  • AnsariK, KeaneyN, TaylorI, BurnsG, FarrowM. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease. Postgrad Med J. 2012;88(1041):372–376. doi:10.1136/postgradmedj-2011-13029322388793
  • JeongM, KangHK, SongP, et al. Hand grip strength in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2385–2390. doi:10.2147/COPD.S14091528848339
  • BoneAE, HepgulN, KonS, MaddocksM. Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis. 2017;14(1):85–99. doi:10.1177/147997231667966427923981
  • JaitovichA, BarreiroE. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. What we know and can do for our patients. Am J Respir Crit Care Med. 2018;198(2):175–186. doi:10.1164/rccm.201710-2140CI29554438
  • ChainaniV, ShaharyarS, DaveK, et al. Objective measures of the frailty syndrome (hand grip strength and gait speed) and cardiovascular mortality: A systematic review. Int J Cardiol. 2016;215:487–493. doi:10.1016/j.ijcard.2016.04.06827131770
  • MoyML, TeylanM, WestonNA, GagnonDR, GarshickE. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013;8(4):e60400. doi:10.1371/journal.pone.006040023593211
  • Garcia-RioF, RojoB, CasitasR, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012;142(2):338–346. doi:10.1378/chest.11-201422281798
  • Gimeno-SantosE, FreiA, Steurer-SteyC, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69(8):731–739. doi:10.1136/thoraxjnl-2013-20476324558112
  • BurtinC, Ter RietG, PuhanMA, et al. Handgrip weakness and mortality risk in COPD: a multicentre analysis. Thorax. 2016;71(1):86–87. doi:10.1136/thoraxjnl-2015-20745126514408
  • SyddallH, CooperC, MartinF, BriggsR, Aihie SayerA. Is grip strength a useful single marker of frailty? Age Ageing. 2003;32(6):650–656. doi:10.1093/ageing/afg11114600007
  • VelgheA, De BuyserS, NoensL, DemuynckR, PetrovicM. Hand grip strength as a screening tool for frailty in older patients with haematological malignancies. Acta Clin Belg. 2016;71(4):227–230. doi:10.1080/17843286.2016.116238127118256
  • MaddocksM, KonSS, CanavanJL, et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax. 2016;71(11):988–995. doi:10.1136/thoraxjnl-2016-20846027293209
  • SongX, MitnitskiA, RockwoodK. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58(4):681–687. doi:10.1111/j.1532-5415.2010.02764.x20345864